1. COVID-19 in a Subset of Hospitalized Children in Israel
- Author
-
Daniel Grupel, Ellen Bamberger, Halima Dabaja-Younis, Shalom Ben-Shimol, Zohar Steinberg Ben Zeev, Orli Megged, Eugene Leibovitz, Eli Somekh, Oded Scheuerman, Yael Shachor-Meyouhas, David Greenberg, Michal Stein, Noga Givon-Lavi, Uri Rubinstein, Alex Guri, Gilat Livni, Husam Yakub Hanna, Amir A. Kuperman, Meirav Mor, Yoav F Alkan, Dana Danino, Ilan Youngster, Giora Gottesman, Daniel Glikman, Diana Tasher, and Galia Grisaru-Soen
- Subjects
medicine.medical_specialty ,Disease ,pediatric inflammatory multisystem syndrome (PIMS) ,Serology ,03 medical and health sciences ,0302 clinical medicine ,children ,030225 pediatrics ,Internal medicine ,hemic and lymphatic diseases ,Medicine ,Humans ,030212 general & internal medicine ,Prospective Studies ,Israel ,Prospective cohort study ,Child ,Pathological ,multisystem inflammatory syndrome in children (MIS-C) ,business.industry ,SARS-CoV-2 ,COVID-19 ,Infant ,General Medicine ,medicine.disease ,Rash ,Obesity ,Systemic Inflammatory Response Syndrome ,Systemic inflammatory response syndrome ,Infectious Diseases ,AcademicSubjects/MED00290 ,El Niño ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,coronavirus disease 2019 (COVID-19) ,Original Article ,medicine.symptom ,business ,AcademicSubjects/MED00670 ,Child, Hospitalized - Abstract
Background Most pediatric coronavirus disease 2019 (COVID-19) is mild. We assessed nationally severe COVID-19, including pediatric inflammatory multisystem syndrome (PIMS), in hospitalized children. Methods An ongoing, prospective, national surveillance was conducted from March 2020 through March 2021, at 20 hospitals treating children, We assessed pediatric COVID-19 in 20/26 Israeli hospitals. Overall, 568 cases (82% mild disease, 8% moderate/severe disease, and 10% PIMS), representing
- Published
- 2021